Cite
HARVARD Citation
Gattaz, W. et al. (n.d.). Switching from oral risperidone to flexibly dosed oral paliperidone extended-release: core symptoms, satisfaction, and quality of life in patients with stable but symptomatic schizophrenia: the RISPALI study. Current medical research and opinion. pp. 695-709. [Online].